Trends in treatment of childhood cancer and subsequent primary neoplasm risk

1Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004; 364: 2097-105. doi: 10.1016/S0140-6736(04)17550-8 Steliarova-Foucher E Stiller C Kaatsch P Berrino F Coebergh JW Lacour B et al Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study Lancet 2004 364 2097 105 10.1016/S0140-6736(04)17550-815589307Open DOISearch in Google Scholar

2Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. EUROCARE Working Group. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol 2013; 15: 35-47. doi: 10.1016/S1470-2045(13)70548-5 Gatta G Botta L Rossi S Aareleid T Bielska-Lasota M Clavel J et al EUROCARE Working Group Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol 2013 15 35 47 10.1016/S1470-2045(13)70548-524314616Open DOISearch in Google Scholar

3Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al; Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-82. doi: 10.1056/NEJMsa060185 Oeffinger KC Mertens AC Sklar CA Kawashima T Hudson MM Meadows AT et al; Childhood Cancer Survivor Study Chronic health conditions in adult survivors of childhood cancer N Engl J Med 2006 355 1572 82 10.1056/NEJMsa06018517035650Open DOISearch in Google Scholar

4Vassal G, Schrappe M, Pritchard-Jones K, Arnold F, Basset L, Biondi A, et al. The SIOPE strategic plan: A European cancer plan for children and adolescents. J Cancer Policy 2016; 8: 17-32. doi: 10.1016/j.jcpo.2016.03.007 Vassal G Schrappe M Pritchard-Jones K Arnold F Basset L Biondi A et al The SIOPE strategic plan: A European cancer plan for children and adolescents J Cancer Policy 2016 8 17 32 10.1016/j.jcpo.2016.03.007Open DOISearch in Google Scholar

5Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, et al; British Childhood Cancer Survivor Study Steering Group. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010; 304: 172-9. doi: 10.1001/jama.2010.923 Reulen RC Winter DL Frobisher C Lancashire ER Stiller CA Jenney ME et al; British Childhood Cancer Survivor Study Steering Group Long-term cause-specific mortality among survivors of childhood cancer JAMA 2010 304 172 9 10.1001/jama.2010.92320628130Open DOISearch in Google Scholar

6Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009; 101: 806-13. doi: 10.1093/ jnci/djp104 Olsen JH Möller T Anderson H Langmark F Sankila R Tryggvadóttír L et al Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries J Natl Cancer Inst 2009 101 806 13 10.1093/jnci/djp10419470947Open DOISearch in Google Scholar

7Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, et al, British Childhood Cancer Survivor Study Steering Group. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011; 305: 2311-19. doi: 10.1001/jama.2011.747 Reulen RC Frobisher C Winter DL Kelly J Lancashire ER Stiller CA et al British Childhood Cancer Survivor Study Steering Group Long-term risks of subsequent primary neoplasms among survivors of childhood cancer JAMA 2011 305 2311 19 10.1001/jama.2011.74721642683Open DOISearch in Google Scholar

8Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001; 93: 618-29. doi: 10.1093/jnci/93.8.618 Neglia JP Friedman DL Yasui Y Mertens AC Hammond S Stovall M et al Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study J Natl Cancer Inst 2001 93 618 29 10.1093/jnci/93.8.61811309438Open DOISearch in Google Scholar

9Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009; 27: 2356-62. doi: 10.1200/JCO.2008.21.1920 Meadows AT Friedman DL Neglia JP Mertens AC Donaldson SS Stovall M et al Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort J Clin Oncol 2009 27 2356 62 10.1200/JCO.2008.21.1920273864519255307Open DOISearch in Google Scholar

10Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102: 1083-95. doi: 10.1093/jnci/djq238 Friedman DL Whitton J Leisenring W Mertens AC Hammond S Stovall M et al Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study J Natl Cancer Inst 2010 102 1083 95 10.1093/jnci/djq238290740820634481Open DOISearch in Google Scholar

11Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, et al. Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015. JAMA 2017; 317: 814-24. doi: 10.1001/jama.2017.0693 Turcotte LM Liu Q Yasui Y Arnold MA Hammond S Howell RM et al Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015 JAMA 2017 317 814 24 10.1001/jama.2017.0693Open DOISearch in Google Scholar

12Turcotte LM, Whitton JA, Friedman DL, Hammond S, Armstrong GT, Leisenring W, et al. Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort. J Clin Oncol 2015; 33: 3568-75. doi: 10.1200/JCO.2015.60.9487 Turcotte LM Whitton JA Friedman DL Hammond S Armstrong GT Leisenring W et al Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort J Clin Oncol 2015 33 3568 75 10.1200/JCO.2015.60.9487Open DOISearch in Google Scholar

13Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, et al. DCOG LATER Study Group. Longterm risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER Study Cohort: role of chemotherapy. J Clin Oncol 2017; 35: 2288-98. doi: 10.1200/JCO.2016.71.6902 Teepen JC van Leeuwen FE Tissing WJ van Dulmen-den Broeder E van den Heuvel-Eibrink MM van der Pal HJ et al DCOG LATER Study Group Longterm risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER Study Cohort: role of chemotherapy. J Clin Oncol 2017 35 2288 98 10.1200/JCO.2016.71.6902Open DOISearch in Google Scholar

14Teepen JC, Kremer LC, van der Heiden-van der Loo M, Tissing WJ, van der Pal HJ, van den Heuvel-Eibrink MM, et al. DCOG-LATER Study Group. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort. Cancer Causes Control 2019; 30: 909-22. doi: 10.1007/s10552-019-01204-z Teepen JC Kremer LC van der Heiden-van der Loo M Tissing WJ van der Pal HJ van den Heuvel-Eibrink MM et al DCOG-LATER Study Group Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort. Cancer Causes Control 2019 30 909 22 10.1007/s10552-019-01204-zOpen DOISearch in Google Scholar

15Jazbec J, Ećimović P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004; 42: 574-81. doi: 10.1002/pbc.20025 Jazbec J Ećimović P Jereb B Second neoplasms after treatment of childhood cancer in Slovenia Pediatr Blood Cancer 2004 42 574 81 10.1002/pbc.20025Open DOISearch in Google Scholar

16Jereb B. Model for long-term follow-up of survivors of childhood cancer. Med Pediatr Oncol 2000; 34: 256-8. doi: 10.1002/(sici)1096-911x(200004)34:4<256::aid-mpo5>3.0.co;2-8 Jereb B Model for long-term follow-up of survivors of childhood cancer Med Pediatr Oncol 2000 34 256 8 10.1002/(sici)1096-911x(200004)34:4<256::aid-mpo5>3.0.co;2-8Open DOISearch in Google Scholar

17International Classification of Diseases for Oncology. Third Edition, First Revision. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al, editors. Geneva: World Health Organization; 2013. International Classification of Diseases for Oncology Third Edition, First Revision Fritz A Percy C Jack A Shanmugaratnam K Sobin L Parkin DM et al, editors Geneva World Health Organization; 2013Search in Google Scholar

18Cancer registration: principles and methods. Jensen OM, Parkin DM, MacLennan R, Muir C, Skeet RG, editors. Lyon, France: World Health Organization, IARC Sci Publ; 1991. p. 95. Cancer registration: principles and methods Jensen OM Parkin DM MacLennan R Muir C Skeet RG editors Lyon, France World Health Organization, IARC Sci Publ; 1991 p 95Search in Google Scholar

19dos Santos Silva I. Cancer epidemiology: principles and methods. First edition. Lyon: International Agency for Research on Cancer, World Health Organization; 1999. dos Santos Silva I Cancer epidemiology: principles and methods. First edition Lyon International Agency for Research on Cancer, World Health Organization; 1999Search in Google Scholar

20Thernau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York, NY: Springer-Verlag; 2000. doi.org/10.1007/978-1-4757-3294-8 Thernau TM Grambsch PM Modelling survival data: extending the Cox model New York, NY Springer-Verlag 2000 doi.org/10.1007/978-1-4757-3294-810.1007/978-1-4757-3294-8Search in Google Scholar

21Dickman PW, Coviello E. “Estimating and modeling relative survival.” Stata J 2015; 15: 186-215. doi: 10.1177/1536867X1501500112 Dickman PW Coviello E. “Estimating and modeling relative survival.” Stata J 2015 15 186 215 10.1177/1536867X1501500112Open DOISearch in Google Scholar

22Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, et al. Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: a review. J Clin Oncol 2018; 36: 2145-52. doi: 10.1200/JCO.2017.76.7764 Turcotte LM Neglia JP Reulen RC Ronckers CM van Leeuwen FE Morton LM et al Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: a review J Clin Oncol 2018 36 2145 52 10.1200/JCO.2017.76.7764Open DOISearch in Google Scholar

23Jairam V, Roberts KB, Yu JB. Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys 2013; 85: e151-5. doi: 10.1016/j.ijrobp.2012.10.007 Jairam V Roberts KB Yu JB Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008 Int J Radiat Oncol Biol Phys 2013 85 e151 5 10.1016/j.ijrobp.2012.10.007Open DOISearch in Google Scholar

24Richards S, Pui CH, Gayon P; Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG). Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2013; 60: 185-95. doi: 10.1002/pbc.24228 Richards S Pui CH Gayon P; Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG) Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia Pediatr Blood Cancer 2013 60 185 95 10.1002/pbc.24228346108422693038Open DOISearch in Google Scholar

25Vora A, Andreano A, Pui CH, Hunger SP, Schrappe M, Moericke A, et al. Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy. J Clin Oncol 2016; 34: 919-26. doi: 10.1200/JCO.2015.64.2850 Vora A Andreano A Pui CH Hunger SP Schrappe M Moericke A et al Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy J Clin Oncol 2016 34 919 26 10.1200/JCO.2015.64.2850487199826755523Open DOISearch in Google Scholar

26Pritchard-Jones K. Childhood cancer in Britain: incidence, survival, and mortality. Br J Cancer 2007; 96: 1927. doi: 10.1038/sj.bjc.6603800 Pritchard-Jones K. Childhood cancer in Britain: incidence, survival, and mortality Br J Cancer 2007 96 1927 10.1038/sj.bjc.6603800Open DOISearch in Google Scholar

27Abramson DH. Retinoblastoma in the 20th Century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005; 46: 268491. doi: 10.1167/iovs.04-1462 Abramson DH Retinoblastoma in the 20th Century: past success and future challenges the Weisenfeld lecture Invest Ophthalmol Vis Sci 2005 46 268491 10.1167/iovs.04-146216043839Open DOISearch in Google Scholar

28Schonfeld SJ, Kleinerman RA, Abramson DH, Seddon JM, Tucker MA, Morton LM. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. Br J Cancer 2021; 124: 1312-19. doi: 10.1038/s41416-020-01248-y Schonfeld SJ Kleinerman RA Abramson DH Seddon JM Tucker MA Morton LM Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors Br J Cancer 2021 124 1312 19 10.1038/s41416-020-01248-y800757433473166Open DOISearch in Google Scholar

29Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, et al. PanCareSurFup Consortium. Risk of soft-tissue sarcoma among 69,460 five-year survivors of childhood cancer in Europe. J Natl Cancer Inst 2018; 110: 649–66. doi: 10.1093/jnci/djx235 Bright CJ Hawkins MM Winter DL Alessi D Allodji RS Bagnasco F et al PanCareSurFup Consortium Risk of soft-tissue sarcoma among 69,460 five-year survivors of childhood cancer in Europe. J Natl Cancer Inst 2018 110 649 66 10.1093/jnci/djx235600501929165710Open DOISearch in Google Scholar

30Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bárdi E, et al. Risk of subsequent bone cancers among 69,460 five-year survivors of childhood and adolescent cancer in Europe. J Natl Cancer Inst 2018; 110: 183-94. doi: 10.1093/jnci/djx165. PMID: 28954302 Fidler MM Reulen RC Winter DL Allodji RS Bagnasco F Bárdi E et al Risk of subsequent bone cancers among 69,460 five-year survivors of childhood and adolescent cancer in Europe J Natl Cancer Inst 2018 110 183 94 10.1093/jnci/djx165.PMID:28954302Open DOISearch in Google Scholar

31Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, et al. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2007; 99: 300-8. doi: 10.1093/jnci/djk052 Henderson TO Whitton J Stovall M Mertens AC Mitby P Friedman D et al Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study J Natl Cancer Inst 2007 99 300 8 10.1093/jnci/djk05217312307Open DOISearch in Google Scholar

32Garwicz S, Anderson H, Olsen JH, Døllner H, Hertz H, Jonmundsson G, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. Int J Cancer 2000; 88: 672-8. doi: 10.1002/1097-0215(20001115)88:4<672::aid-ijc24>3.0.co;2-n Garwicz S Anderson H Olsen JH Døllner H Hertz H Jonmundsson G et al Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries Int J Cancer 2000 88 672 8 10.1002/1097-0215(20001115)88:4<672::aid-ijc24>3.0.co;2-nOpen DOISearch in Google Scholar

33Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, et al. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: a cohort study within PanCareSurFup. Eur J Cancer 2019; 117: 71-83. doi: 10.1016/j.ejca.2019.05.013 Allodji RS Hawkins MM Bright CJ Fidler-Benaoudia MM Winter DL Alessi D et al Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: a cohort study within PanCareSurFup Eur J Cancer 2019 117 71 83 10.1016/j.ejca.2019.05.013Open DOISearch in Google Scholar

34Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, et al. Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood 2011; 117: 6315-8. doi: 10.1182/blood-2011-02-335158 Nottage K Lanctot J Li Z Neglia JP Bhatia S Hammond S et al Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study Blood 2011 117 6315 8 10.1182/blood-2011-02-335158312294921498675Open DOISearch in Google Scholar

35Bagnasco F, Caruso S, Andreano A, Valsecchi MG, Jankovic M, Biondi A, et al. OTR-AIEOP Registry. Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer 2019; 110: 86-97. doi: 10.1016/j.ejca.2018.12.021 Bagnasco F Caruso S Andreano A Valsecchi MG Jankovic M Biondi A et al OTR-AIEOP Registry Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer 2019 110 86 97 10.1016/j.ejca.2018.12.02130772657Open DOISearch in Google Scholar